Our Company

 

Shanton Pharma is a clinical-stage biotech company founded in 2016, with a research focus on the unmet needs associated with gout, hyperuricemia, and pruritus. Our team focuses its resources on these important therapeutic areas through advanced and innovative drug research and developmental approaches.

Read More

Our Science

Our mission is to develop treatments to address global clinical unmet
needs associated with gout, hyperuricemia, and pruritus.

 

Disease Areas

 

Shanton Pharma is dedicated to researching and developing novel
and innovative solutions for gout, hyperuricemia, and pruritus.

Read More
 

Pipeline

 

We have established a strong pipeline of
clinical and preclinical programs.

Read More